Shree Pacetronix Ltd
Incorporated in 1988, Shree Pacetronix Ltd manufactures and exports Implantable Cardiac Pacemakers.
- Market Cap ₹ 64.7 Cr.
- Current Price ₹ 180
- High / Low ₹ 392 / 96.2
- Stock P/E 16.5
- Book Value ₹ 31.5
- Dividend Yield 0.00 %
- ROCE 45.8 %
- ROE 39.8 %
- Face Value ₹ 10.0
Pros
- Debtor days have improved from 171 to 109 days.
- Company's working capital requirements have reduced from 175 days to 119 days
Cons
- Though the company is reporting repeated profits, it is not paying out dividend
- Promoter holding is low: 24.2%
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Sector: Healthcare Industry: Healthcare
Quarterly Results
Standalone Figures in Rs. Crores / View Consolidated
Profit & Loss
Standalone Figures in Rs. Crores / View Consolidated
Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | TTM | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
7.02 | 6.30 | 7.11 | 6.49 | 7.40 | 6.84 | 6.60 | 7.27 | 8.76 | 7.56 | 9.03 | 20.19 | 22.91 | |
6.13 | 5.22 | 5.82 | 5.34 | 6.22 | 6.34 | 5.80 | 6.52 | 7.52 | 6.45 | 7.44 | 14.75 | 16.53 | |
Operating Profit | 0.89 | 1.08 | 1.29 | 1.15 | 1.18 | 0.50 | 0.80 | 0.75 | 1.24 | 1.11 | 1.59 | 5.44 | 6.38 |
OPM % | 12.68% | 17.14% | 18.14% | 17.72% | 15.95% | 7.31% | 12.12% | 10.32% | 14.16% | 14.68% | 17.61% | 26.94% | 27.85% |
0.09 | 0.04 | 0.01 | -0.15 | -0.08 | 0.05 | 0.01 | 0.17 | 0.04 | 0.05 | 0.07 | 0.09 | 0.13 | |
Interest | 0.45 | 0.41 | 0.46 | 0.41 | 0.35 | 0.38 | 0.31 | 0.30 | 0.36 | 0.34 | 0.28 | 0.30 | 0.35 |
Depreciation | 0.51 | 0.53 | 0.51 | 0.68 | 0.69 | 0.57 | 0.39 | 0.38 | 0.51 | 0.51 | 0.50 | 0.63 | 0.74 |
Profit before tax | 0.02 | 0.18 | 0.33 | -0.09 | 0.06 | -0.40 | 0.11 | 0.24 | 0.41 | 0.31 | 0.88 | 4.60 | 5.42 |
Tax % | 50.00% | 33.33% | 33.33% | 66.67% | 116.67% | 27.50% | 36.36% | 41.67% | 31.71% | 41.94% | 26.14% | 29.35% | |
0.00 | 0.11 | 0.22 | -0.04 | -0.01 | -0.29 | 0.08 | 0.14 | 0.28 | 0.18 | 0.65 | 3.25 | 3.92 | |
EPS in Rs | 0.00 | 0.31 | 0.61 | -0.11 | -0.03 | -0.81 | 0.22 | 0.39 | 0.78 | 0.50 | 1.81 | 9.03 | 10.89 |
Dividend Payout % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Compounded Sales Growth | |
---|---|
10 Years: | 12% |
5 Years: | 25% |
3 Years: | 32% |
TTM: | 53% |
Compounded Profit Growth | |
---|---|
10 Years: | 40% |
5 Years: | 110% |
3 Years: | 129% |
TTM: | 155% |
Stock Price CAGR | |
---|---|
10 Years: | 32% |
5 Years: | 69% |
3 Years: | 150% |
1 Year: | 71% |
Return on Equity | |
---|---|
10 Years: | 7% |
5 Years: | 14% |
3 Years: | 20% |
Last Year: | 40% |
Balance Sheet
Standalone Figures in Rs. Crores / View Consolidated
Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Sep 2023 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Equity Capital | 3.60 | 3.60 | 3.60 | 3.60 | 3.60 | 3.60 | 3.60 | 3.60 | 3.60 | 3.60 | 3.60 | 3.60 | 3.60 |
Reserves | 1.55 | 1.66 | 1.88 | 1.81 | 1.80 | 1.51 | 1.70 | 1.84 | 2.11 | 2.30 | 2.95 | 6.20 | 7.73 |
2.81 | 2.55 | 2.08 | 2.69 | 1.89 | 2.64 | 2.30 | 2.94 | 2.64 | 2.73 | 2.88 | 2.16 | 3.41 | |
1.20 | 1.17 | 1.27 | 0.95 | 1.31 | 1.28 | 1.29 | 1.27 | 1.99 | 2.07 | 2.62 | 4.64 | 5.66 | |
Total Liabilities | 9.16 | 8.98 | 8.83 | 9.05 | 8.60 | 9.03 | 8.89 | 9.65 | 10.34 | 10.70 | 12.05 | 16.60 | 20.40 |
3.30 | 3.16 | 3.10 | 2.89 | 2.40 | 1.94 | 1.84 | 2.36 | 2.43 | 2.65 | 2.51 | 3.07 | 3.66 | |
CWIP | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.77 | 0.00 | 0.00 | 0.11 | 0.00 | 0.00 | 0.00 | 0.00 |
Investments | 0.80 | 0.80 | 0.80 | 0.80 | 0.80 | 0.80 | 0.80 | 0.80 | 0.80 | 0.80 | 0.80 | 0.80 | 0.80 |
5.06 | 5.02 | 4.93 | 5.36 | 5.40 | 5.52 | 6.25 | 6.49 | 7.00 | 7.25 | 8.74 | 12.73 | 15.94 | |
Total Assets | 9.16 | 8.98 | 8.83 | 9.05 | 8.60 | 9.03 | 8.89 | 9.65 | 10.34 | 10.70 | 12.05 | 16.60 | 20.40 |
Cash Flows
Standalone Figures in Rs. Crores / View Consolidated
Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
0.43 | 0.73 | 1.13 | 0.36 | 1.32 | 0.57 | 0.08 | 0.63 | 1.49 | 0.99 | 0.59 | 2.45 | |
0.32 | -0.34 | -0.44 | -0.49 | -0.21 | -0.89 | 0.45 | -0.75 | -0.56 | -0.58 | -1.10 | -1.41 | |
-0.73 | -0.63 | -0.90 | 0.19 | -1.11 | 0.24 | -0.48 | 0.26 | -0.81 | -0.15 | -0.14 | -1.01 | |
Net Cash Flow | 0.02 | -0.24 | -0.21 | 0.07 | 0.00 | -0.07 | 0.06 | 0.14 | 0.12 | 0.26 | -0.65 | 0.03 |
Ratios
Standalone Figures in Rs. Crores / View Consolidated
Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Debtor Days | 71.75 | 82.27 | 91.38 | 64.68 | 78.92 | 102.46 | 174.20 | 154.13 | 162.50 | 194.57 | 209.78 | 108.65 |
Inventory Days | 241.69 | 543.26 | 484.22 | 746.59 | 359.32 | 373.73 | 301.93 | 270.24 | 217.26 | 272.02 | 194.20 | 157.41 |
Days Payable | 75.63 | 95.49 | 40.35 | 33.18 | 32.67 | 27.63 | 48.31 | 33.93 | 53.23 | 47.19 | 17.55 | 32.22 |
Cash Conversion Cycle | 237.81 | 530.03 | 535.25 | 778.09 | 405.57 | 448.55 | 427.83 | 390.45 | 326.53 | 419.40 | 386.43 | 233.84 |
Working Capital Days | 164.82 | 184.82 | 180.19 | 227.77 | 182.01 | 193.71 | 240.57 | 221.91 | 167.50 | 205.19 | 202.10 | 119.14 |
ROCE % | 5.67% | 7.48% | 10.28% | 3.83% | 5.33% | -0.40% | 5.47% | 5.13% | 9.09% | 7.54% | 12.51% | 45.82% |
Documents
Announcements
-
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
15 Apr - In accordance with Regulation 74(5) of the SEBI (Depositories and Participants) Regulation, 2018 for the quarter ended 31st March, 2024, based on the certificate (enclosed …
- Submission Of Compliance Certificate Under Regulation 7(3) Of SEBI (LODR) Regulations, 2015 11 Apr
- Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011 1 Apr
- Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011. 30 Mar
- Closure of Trading Window 29 Mar
Annual reports
-
Financial Year 2023
from bse
-
Financial Year 2022
from bse
-
Financial Year 2021
from bse
-
Financial Year 2020
from bse
-
Financial Year 2019
from bse
-
Financial Year 2018
from bse
-
Financial Year 2017
from bse
-
Financial Year 2016
from bse
-
Financial Year 2015
from bse
-
Financial Year 2014
from bse
-
Financial Year 2013
from bse
-
Financial Year 2012
from bse
-
Financial Year 2011
from bse
-
Financial Year 2010
from bse
-
Financial Year 2008
from bse
Product Profile:[1][2]
Company deals in 3 major products viz, Pacemakers, Pacing Leads, Pacing System which are further bifurcated as: Ventralite 940+/ Tiranga, Pinnacle-8820, Tiranga -302, Pinnacle-R-SSIR-Model-29, Trinity-R, Smart - E, Atrial-J-Bipolar-Lead-3851-VB, Introducer, Zeus -1, Is1 Bipolar Lead 3851 Vb, Screw-in Lead P12, Pace Maker Analyser, Charak DDDR, Indus I SSB, Implantable Cardioverter Pacemaker, Single Chamber Pacemaker, Reuters Pacemakers, Permanent Pacemaker, Medtronic Pacemaker, Pacing System Analyzer